Apolipoprotein D is associated with long-term outcome in patients with schizophrenia.
Hansen T, Hemmingsen RP, Wang AG, Olsen L, Timm S, Søeby K, Jakobsen KD, Fenger M, Parnas J, Rasmussen HB, Werge T.
Hansen T, et al. Among authors: fenger m.
Pharmacogenomics J. 2006 Mar-Apr;6(2):120-5. doi: 10.1038/sj.tpj.6500350.
Pharmacogenomics J. 2006.
PMID: 16402085